Literature DB >> 15997387

[Role of adrenomedullin in the pathogenesis and treatment of cardiovascular dysfunctions and sepsis].

M Westphal1, J Sander, H Van Aken, C Ertmer, H D Stubbe, M Booke.   

Abstract

Adrenomedullin (AM) is an endogenous vasodilatory peptide hormone, which plays a key role in the regulation and preservation of cardiovascular and pulmonary functions. Clinical and experimental studies have demonstrated that AM represents an alternative therapeutic option in the treatment of pulmonary hypertension. In addition, AM proved to be useful in the treatment of cardiovascular dysfunctions, such as arterial hypertension and congestive heart failure following myocardial infarction. Recent research has also shown that AM plays a pivotal role in the development of sepsis-associated hemodynamic and microcirculatory disorders. Experimental studies also suggest that infusion of exogenous AM might be a rational approach to prevent and treat hypodynamic septic shock. The objectives of this review article are to characterize the regulative properties of AM and to discuss clinical and experimental studies which allow to judge the role of AM in the setting of cardiovascular dysfunction and sepsis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15997387     DOI: 10.1007/s00101-005-0888-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  65 in total

1.  Adrenomedullin is upregulated in the heart and aorta during the early and late stages of sepsis.

Authors:  M Zhou; I H Chaudry; P Wang
Journal:  Biochim Biophys Acta       Date:  1999-02-24

2.  The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis.

Authors:  P Wang; Z F Ba; W G Cioffi; K I Bland; I H Chaudry
Journal:  Arch Surg       Date:  1998-12

3.  Long-term adrenomedullin administration in experimental heart failure.

Authors:  Miriam T Rademaker; Chris J Charles; Eric A Espiner; M Gary Nicholls; A Mark Richards
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

Review 4.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

5.  Saturation of adrenomedullin receptors plays an important role in reducing pulmonary clearance of adrenomedullin during the late stage of sepsis.

Authors:  David A Ornan; Irshad H Chaudry; Ping Wang
Journal:  Biochim Biophys Acta       Date:  2002-04-24

6.  Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction.

Authors:  Noritoshi Nagaya; Yoichi Goto; Toru Satoh; Hitoshi Sumida; Sunao Kojima; Kunio Miyatake; Kenji Kangawa
Journal:  J Cardiovasc Pharmacol       Date:  2002-05       Impact factor: 3.105

7.  Long-term adrenomedullin infusion improves survival in malignant hypertensive rats.

Authors:  Yosuke Mori; Toshio Nishikimi; Naohiko Kobayashi; Hidehiko Ono; Kenji Kangawa; Hiroaki Matsuoka
Journal:  Hypertension       Date:  2002-07       Impact factor: 10.190

8.  Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats.

Authors:  Ryosai Nakamura; Johji Kato; Kazuo Kitamura; Hisamitsu Onitsuka; Takuroh Imamura; Kousuke Marutsuka; Yujiro Asada; Kenji Kangawa; Tanenao Eto
Journal:  Cardiovasc Res       Date:  2002-12       Impact factor: 10.787

9.  Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells.

Authors:  S Sugo; N Minamino; H Shoji; K Kangawa; K Kitamura; T Eto; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

10.  Plasma adrenomedullin concentrations in essential hypertension.

Authors:  M Kohno; T Hanehira; H Kano; T Horio; K Yokokawa; M Ikeda; M Minami; K Yasunari; J Yoshikawa
Journal:  Hypertension       Date:  1996-01       Impact factor: 10.190

View more
  2 in total

Review 1.  TRPV1 and SP: key elements for sepsis outcome?

Authors:  Jennifer Victoria Bodkin; Elizabeth Soares Fernandes
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model.

Authors:  Joachim Struck; Frauke Hein; Siegmund Karasch; Andreas Bergmann
Journal:  Intensive Care Med Exp       Date:  2013-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.